The United Laboratories International Holdings Limited provided earnings guidance for the year ended December 31, 2012. Based on the unaudited consolidated management accounts of the company for the year ended December 31, 2012 prepared in accordance with Hong Kong Financial Reporting Standards, the estimated net profit of the Group for the year ended December 31, 2012 is expected to be at least 1.5 times of that for the year ended 31 December 2011. The increase in net profit for the year ended December 31, 2012 is mainly attributable to the following factors: The increase in gain on fair value change of derivative components of convertible bonds; Increase in export sales of the Group's bulk medicine and intermediate products and decrease in overall production costs; and Continued increase in sales of the Group's finished products as a result of the Group's expansion in China's rural market.